Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17025836 | GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA | Final Rejection | The Regents of the University of California |
| 18171862 | METHOD FOR PRODUCING THREE-DIMENSIONAL CELL STRUCTURE, AND THREE-DIMENSIONAL CELL STRUCTURE | Final Rejection | TOPPAN Inc. |
| 18408498 | RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING | Non-Final OA | President and Fellows of Harvard College |
| 18012064 | PROGRAMMABLE ORGANOIDS AND METHODS OF PRODUCING THE SAME VIA ORTHOGONAL DIFFERENTIATION AND BIOPRINTING | Final Rejection | President and Fellows of Harvard College |
| 18659959 | NEUROPROTECTION GENE THERAPY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17780170 | IMAGING INDIVIDUAL HIPPOCAMPAL SEIZURES AND THE LONG-TERM IMPACT OF REPEATED SEIZURES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17920069 | NON-HUMAN ANIMALS HAVING A HUMANIZED CXCL13 GENE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17921217 | MULTI-LINEAGE CARDIOVASCULAR MICROFLUIDIC ORGAN-CHIP | Non-Final OA | CEDARS-SINAI MEDICAL CENTER |
| 17922731 | USE OF CD34 AS A MARKER FOR SINOATRIAL NODE-LIKE PACEMAKER CELLS | Final Rejection | UNIVERSITY HEALTH NETWORK |
| 18002009 | CHIMERIC ANTIGEN RECEPTOR-EXPRESSING IMMUNOCOMPETENT CELLS | Non-Final OA | KYOTO UNIVERSITY |
| 17371017 | MYBPC3 POLYPEPTIDES AND USES THEREOF | Final Rejection | Children's Medical Center Corporation |
| 18716858 | METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING HUMAN GUT MICROBES | Non-Final OA | Cornell University |
| 18799294 | METHODS OF IN VITRO DIFFERENTIATION OF MIDBRAIN DOPAMINE (MDA) NEURONS | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 17310051 | FIBROBLASTS AND MICROVESICLES THEREOF FOR REDUCTION OF TOXICITY ASSOCIATED WITH CANCER IMMUNOTHERAPY | Final Rejection | Figene, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy